Calcoen, B.; Callewaert, N.; Vandenbulcke, A.; Kerstens, W.; Imbrechts, M.; Vercruysse, T.; Dallmeier, K.; Van Weyenbergh, J.; Maes, P.; Bossuyt, X.;
et al. High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium. Viruses 2022, 14, 1257.
https://doi.org/10.3390/v14061257
AMA Style
Calcoen B, Callewaert N, Vandenbulcke A, Kerstens W, Imbrechts M, Vercruysse T, Dallmeier K, Van Weyenbergh J, Maes P, Bossuyt X,
et al. High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium. Viruses. 2022; 14(6):1257.
https://doi.org/10.3390/v14061257
Chicago/Turabian Style
Calcoen, Bas, Nico Callewaert, Aline Vandenbulcke, Winnie Kerstens, Maya Imbrechts, Thomas Vercruysse, Kai Dallmeier, Johan Van Weyenbergh, Piet Maes, Xavier Bossuyt,
and et al. 2022. "High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium" Viruses 14, no. 6: 1257.
https://doi.org/10.3390/v14061257
APA Style
Calcoen, B., Callewaert, N., Vandenbulcke, A., Kerstens, W., Imbrechts, M., Vercruysse, T., Dallmeier, K., Van Weyenbergh, J., Maes, P., Bossuyt, X., Zapf, D., Dieckmann, K., Callebaut, K., Thibaut, H. J., Vanhoorelbeke, K., De Meyer, S. F., Maes, W., & Geukens, N.
(2022). High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium. Viruses, 14(6), 1257.
https://doi.org/10.3390/v14061257
